Employer adds universal step restrictions in September, more drug classes to be hit
Medicare & Reimbursement Advisor Weekly, August 26, 2009
To continue providing what it says is affordable access to prescription drugs, Principal Life Insurance Company will implement a national formulary and step therapy policy change in all states except Texas, starting September 15. Most branded drugs move from tier 2 to tier 3 and add a step and/or prior authorization (PA).
Generic “alternatives,” according to the company, will be available on tier 1.
For prescriptions filled on or after September 15, an additional 10 drug classes will be added to the step therapy program. At that time, both current and first-time users of third-tier drugs will need to try an alternative generic drug if they do not have a history of a generic drug within the past 24 months.
When a member wants to fill a prescription for a third-tier drug, the pharmacy system will check whether the member has received an alternative generic drug within the last 24 months.
CVS Caremark sent communications to members and physicians August 15, which included a list of impacted scripts.
Below are the primary changes (see chart). Tier changes apply to all drugs listed.
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched
